ONALABS has been selected by the CIMTI acceleration platform to focus on and strengthen the strategic line of non-invasive devices.
CIMTI has evaluated ONALABS’s idea and the technological impact of its value proposition, as well as the viability of the innovative solution for remotely monitoring chronic cardiorespiratory patients.